fbpixel
Glycoair Breezhaler
Formulation
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains:
Indacaterol 85 mcg
Glycopyrronium 43 mcg

Indacaterol Maleate + Glycopyrronium Bromide

Glycoair™ Breezhaler®

Prescription Drug

Indication

Once-daily maintenance bronchodilator to relieve symptoms and reduce exacerbations in adult patients with chronic obstructive pulmonary disease (COPD).

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.